These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
207 related items for PubMed ID: 22348983
1. Effects of 3 years of lasofoxifene treatment on bone turnover markers in women with postmenopausal osteoporosis. Eastell R, Reid DM, Vukicevic S, Ensrud KE, LaCroix AZ, Thompson JR, Thompson DD, Cummings SR. Bone; 2012 May; 50(5):1135-40. PubMed ID: 22348983 [Abstract] [Full Text] [Related]
2. A randomised, double-blinded, placebo-controlled, trial to determine the individual response in bone turnover markers to lasofoxifene therapy. Rogers A, Glover SJ, Eastell R. Bone; 2009 Dec; 45(6):1044-52. PubMed ID: 19665601 [Abstract] [Full Text] [Related]
9. Reduction in PINP, a marker of bone metabolism, with raloxifene treatment and its relationship with vertebral fracture risk. Reginster JY, Sarkar S, Zegels B, Henrotin Y, Bruyere O, Agnusdei D, Collette J. Bone; 2004 Feb; 34(2):344-51. PubMed ID: 14962813 [Abstract] [Full Text] [Related]
11. Fracture risk reduction during treatment with teriparatide is independent of pretreatment bone turnover. Delmas PD, Licata AA, Reginster JY, Crans GG, Chen P, Misurski DA, Wagman RB, Mitlak BH. Bone; 2006 Aug; 39(2):237-43. PubMed ID: 16563890 [Abstract] [Full Text] [Related]
12. The relationship of biochemical markers of bone turnover to bone density changes in postmenopausal women: results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) trial. Marcus R, Holloway L, Wells B, Greendale G, James MK, Wasilauskas C, Kelaghan J. J Bone Miner Res; 1999 Sep; 14(9):1583-95. PubMed ID: 10469288 [Abstract] [Full Text] [Related]
13. Reference intervals of biochemical bone turnover markers for Saudi Arabian women: a cross-sectional study. Ardawi MS, Maimani AA, Bahksh TA, Rouzi AA, Qari MH, Raddadi RM. Bone; 2010 Oct; 47(4):804-14. PubMed ID: 20659600 [Abstract] [Full Text] [Related]
19. Estrogen-dependent increase in bone turnover and bone loss in postmenopausal women with breast cancer treated with anastrozole. Prevention with bisphosphonates. Confavreux CB, Fontana A, Guastalla JP, Munoz F, Brun J, Delmas PD. Bone; 2007 Sep; 41(3):346-52. PubMed ID: 17618847 [Abstract] [Full Text] [Related]